|
⚲
|
| Keyboard |
| Column Group II Management LP
✚
|
|
|---|---|
| CIK # | 0001600420, 0001783952 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Revolution Medicines Inc | 277.6 | ||
| Nurix Therapeutics Inc | 235.8 | ||
| Oric Pharmaceuticals Inc | 119.3 | ||
| Holdings by Sector ($M) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001600420] | |
| 3 | [0001600420] | |
| 4 | [0001600420] | |
| D | [0001600420] | |
| SC 13D | [0001600420] | |
| SC 13G | [0001600420] | |
| 3 | [0001783952] | |
| 4 | [0001783952] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
RAPT Therapeutics Inc RAPT
Warrant (right to purchase) · derivative
|
2024-12-23 | Other | 1,352,008 | ||
|
RAPT Therapeutics Inc RAPT
Warrant (right to purchase) · derivative
|
2024-12-23 | Other | 1,352,008 | ||
|
RAPT Therapeutics Inc RAPT
Warrant (right to purchase) · derivative
|
2024-12-23 | Other | 1,599,417 | ||
|
RAPT Therapeutics Inc RAPT
Common Stock
|
2024-12-23 | Other | 1,599,417 | ||
|
RAPT Therapeutics Inc RAPT
Warrant (right to purchase) · derivative
|
2024-12-23 | Other | 1,599,417 | ||
|
RAPT Therapeutics Inc RAPT
Common Stock
|
2024-12-23 | Other | 1,352,008 | ||
|
RAPT Therapeutics Inc RAPT
Common Stock
|
2024-12-23 | Other | 1,599,417 | ||
|
RAPT Therapeutics Inc RAPT
Common Stock
|
2024-12-23 | Other | 1,352,008 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 1,298,908 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 100,000 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 100,000 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 15,000 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 44,000 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 2,265,758 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 1,298,908 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 949,862 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 2,650,177 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 90,442 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 11,103,333 | ||
|
NGM Biopharmaceuticals Inc NGM
Common Stock
|
2024-04-05 | Disposed to issuer | 858,035 | ||
| showing 20 of 200 most recent transactions | |||||